Search Results - María Queralt Salas

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies

    Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploi... by Arjun Law, María Queralt Salas, Wilson Lam, Fotios V. Michelis, Santhosh Thyagu, Dennis Dong Hwan Kim, Jeffrey H. Lipton, Rajat Kumar, Hans A. Messner, Auro Viswabandya

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Prospective Pilot Study

    Reduced Dose of Post-Transplant Cyclophosphamide with Tacrolimus for the Prevention of Graft-versus-Host Disease in HLA-Matched Donor Peripheral Blood Stem Cell Transplants: A Pros... by Alex Juárez, María Queralt Salas, Alexandra Pedraza, María Suárez‐Lledó, Luis Gerardo Rodríguez‐Lobato, María Teresa Solano, Anna Serrahima, Meritxell Nomdedéu, Joan Cid, Miquel Lozano, Paola Charry, Jordi Arcarons, Noemi de Llobet‐Viladons, Laura Rosiñol, Francesc Fernández‐Avilés, Montserrat Rovira, Carmen Martı́nez

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant

    Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant by Amanda Isabel Pérez‐Valencia, Enric Cascos, Sara Carbonell-Ordeig, Paola Charry, Marta Gómez‐Hernando, Luis Gerardo Rodríguez‐Lobato, María Suárez‐Lledó, Núria Martínez‐Cibrián, Gabriela Antelo, María Teresa Solano, Jordi Arcarons, Meritxell Nomdedéu, Joan Cid, Miquel Lozano, Maribel Díaz‐Ricart, Laura Rosiñol, Jordi Esteve, Álvaro Urbano-Ispízua, Enric Carreras, Carmen Martı́nez, Francesc Fernández‐Avilés, Montserrat Rovira, María Queralt Salas

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)

    Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish... by Carlos Jiménez‐Vicente, Jordi Esteve, Mónica Baile-González, Estefanía Pérez‐López, Carmen Calvo, Clara Aparicio, Itziar Oiartzabal Ormategi, Albert Esquirol, Felipe Peña-Muñóz, Sara Fernández-Luis, Inmaculada Heras Fernando, Ana Pilar González-Rodríguez, Alberto López-García, José Luis López Lorenzo, Tamara Torrado, Adolfo Saez, Cynthia Acosta Fleytas, Lucía García, Sara Villar, Silvia Filaferro, Pascual Balsalobre, María Jesús Pascual Cascón, María Queralt Salas

    Published 2025
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care

    Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care by María Queralt Salas, María Teresa Solano, Mónica Baile González, Marina Acera Gómez, María Laura Fox, María del Mar Pérez Artigas, Ana Raquel Santa-Maria, María del Carmen Quintela González, Andrés Sánchez‐Salinas, Joaquina M. Salmerón Camacho, Verónica Illana Álvaro, Zahra Abdallahi-Lefdil, Javier Cornago Navascués, Laura Pardo, Sara Fernández-Luis, Leddy Patricia Vega Suárez, Sara Villar, Patricia Beorlegui-Murillo, Albert Esquirol, Isabel Izquierdo García, Sonia Rodríguez González, Alberto Mussetti, Esperanza Lavilla, Javier López-Marín, Silvia Filaferro, Ángel Cedillo, Leyre Bento, Anna Sureda

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study

    Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study by Inés Zugasti, Mònica López‐Guerra, Sandra Castaño‐Díez, Daniel Esteban, Alejandro Avendaño, Helena Pomares, Ana Pérez, Sara García-Ávila, Irene Conejo, Cristina de la Fuente Montes, Alexandra Martínez‐Roca, Beatriz Merchán, Carlos Jiménez‐Vicente, Francesca Guijarro, José Álamo, Albert Cortés‐Bullich, Víctor Torrecillas, Lucie Salomon du Mont, Esther Carcelero, Gisela Riu-Viladoms, Lurdes Zamora, Joan Bargay, Ana Triguero, María Suárez‐Lledó, María Queralt Salas, Félix López Cadenas, Fernando Ramos, Blanca Xicoy, David Valcárcel, Montserrat Arnán, Carmen Martı́nez, Montserrat Rovira, Francesc Fernández‐Avilés, María Díez‐Campelo, Jordi Esteve, Marina Díaz‐Beyá

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: